Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Repare Therapeutics Inc (NQ: RPTX )

10.08 +0.01 (+0.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 71,872
Open 10.13
Bid (Size) 9.860 (5)
Ask (Size) 10.67 (1)
Prev. Close 10.07
Today's Range 9.910 - 10.20
52wk Range 8.065 - 18.68
Shares Outstanding 42,077,896
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Repare Therapeutics Announces Plenary Oral Presentation at the 2023 AACR Annual Meeting on Camonsertib and Additional Data Presentations on RP-6306
From Repare Therapeutics Inc.
Via Business Wire
Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
From Repare Therapeutics Inc.
Via Business Wire

Performance

YTD
-25.50%
-25.50%
1 Month
-7.27%
-7.27%
3 Month
-31.89%
-31.89%
6 Month
-13.48%
-13.48%
1 Year
-29.71%
-29.71%

More News

Read More
Repare Therapeutics Inc. (NASDAQ:RPTX) Investor Investigation over Possible Violations of Securities Laws
Via SBWire
Cathie Wood Has Been Building Stakes In Two Little-Known Stocks
Via Talk Markets
Repare Therapeutics's Return On Capital Employed Insights
Via Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Repare Therapeutics Inc. (RPTX) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
Via Benzinga
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
From Repare Therapeutics Inc.
Via Business Wire
Repare Therapeutics Receives $1.5 Million (¥200 million) Payment from Ono Pharmaceuticals
From Repare Therapeutics Inc.
Via Business Wire
Repare Therapeutics Insiders Establish Automatic Securities Disposition Plans
From Repare Therapeutics Inc.
Via Business Wire
Credit Suisse, Autodesk And Other Big Losers From Wednesday
Via Benzinga
Quest Diagnostics To Plunge 16%? Here Are 5 Other Price Target Changes For Thursday
Via Benzinga
Repare Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
From Repare Therapeutics Inc.
Via Business Wire
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
From Repare Therapeutics Inc.
Via Business Wire
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
From Repare Therapeutics Inc.
Via Business Wire
Repare Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
From Repare Therapeutics Inc.
Via Business Wire
Biotech ETF Tops in June: 5 Stocks That Outperform
Via Talk Markets
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
Via Benzinga
United Airlines And 3 Other Stocks Insiders Are Buying
Via Benzinga
Repare Therapeutics to Participate at the Goldman Sachs 43rd Annual Global Healthcare Conference
From Repare Therapeutics Inc.
Via Business Wire
Mid-Afternoon Market Update: Dow Surges Over 200 Points; Immunic Shares Slide
Via Benzinga
Mid-Day Market Update: U.S. Stocks Turn Positive; Nasdaq Jumps 150 Points
Via Benzinga
74 Biggest Movers From Yesterday
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; Hormel Foods Earnings Top Views
Via Benzinga
53 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.